From July 1, 2023 to July 7, 2023, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 12,096,900 shares, representing 0.87% for CNY 100.01 million under the buyback announced on January 9, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5 CNY | -4.94% | -22.60% | -38.35% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-38.35% | 959M | |
+40.09% | 6.16B | |
-16.34% | 4.46B | |
-7.11% | 3.27B | |
+5.14% | 3.2B | |
-0.18% | 2.6B | |
+47.93% | 1.98B | |
-7.15% | 1.7B | |
+0.67% | 1.66B | |
-8.73% | 1.61B |
- Stock Market
- Equities
- 002424 Stock
- News Guizhou Bailing Group Pharmaceutical Co., Ltd.
- Tranche Update on Guizhou Bailing Group Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 9, 2023.